However, baseline and periodic testing may be appropriate for those with pre-existing liver disease, metabolic syndrome, obesity with metabolic risk factors, or unexplained elevated liver enzymes
Furthermore, 77 and 76 percent reported that hyperhidrosis negatively affects their social life and sense of well-being, respectively
(2024, February 29)
Guidelines have evolved considerably from routine medication cessation in 2023 to GLP-1 RA continuation with individualised risk assessment in 20242025, illustrating increasing acknowledgment that certain theoretical risks may be underestimated
Clinical trials involving thousands of participants did not flag UTIs as a significant adverse event
Next, we will discuss human studies about the effects of GLP-1 on the central nervous system (CNS) and cognitive behavior, and animal studies that imply cognitive actions regulated by the hypothalamus